| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/13/2004 | CA2374877C Pharmaceutical formulations and methods comprising intranasal morphine |
| 04/13/2004 | CA2348090C Oral pulsed dose drug delivery system |
| 04/13/2004 | CA2296035C Preparation of oxymorphone, oxycodone and derivatives |
| 04/13/2004 | CA2292248C Novel derivatives of 1,2-dithiolane, process for preparing them and pharmaceutical compositions containing them |
| 04/13/2004 | CA2291608C Neurotrophic factor receptors |
| 04/13/2004 | CA2185983C Process of extracting and purifying biologically effective ingredients from combined medicinal plants and their extract composition |
| 04/13/2004 | CA2147123C Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo |
| 04/08/2004 | WO2004029229A2 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/08/2004 | WO2004029204A2 Substituted pyrimidines |
| 04/08/2004 | WO2004029192A2 Producing method of tien hsien liquid |
| 04/08/2004 | WO2004029056A1 [1,2,4]-TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVE |
| 04/08/2004 | WO2004029053A1 Novel 1,4-diazabicycloalkane derivatives, their preparation and use |
| 04/08/2004 | WO2004029052A1 Process for preparing haloalkyl pyrimidines |
| 04/08/2004 | WO2004029050A1 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof |
| 04/08/2004 | WO2004029048A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/08/2004 | WO2004029044A1 Pyrimidine compounds as therapeutic agents |
| 04/08/2004 | WO2004029043A1 Pyrazole compounds |
| 04/08/2004 | WO2004029019A2 Compounds for the treatment of alzheimer’s disease |
| 04/08/2004 | WO2004028634A1 Method and composition for treating alzheimer's disease and dementias of vascular origin |
| 04/08/2004 | WO2004028558A1 Preventives/remedies for neurodegenerative disease |
| 04/08/2004 | WO2004028548A2 Inhibitors of the nitrix oxide synthase iii (nos iii) as neuroprotective agents |
| 04/08/2004 | WO2004028544A1 Use of mas-compounds for treating diseases associated with lipid metabolism |
| 04/08/2004 | WO2004028540A1 Anti-neurodegenerative agents |
| 04/08/2004 | WO2004028537A1 Use of thiazolidinedione derivatives as aldose reductase inhibitors |
| 04/08/2004 | WO2004028532A1 Combined use of methylphenidate and melatonin for treating attention-deficit hyperactive disorder |
| 04/08/2004 | WO2004028528A1 Amino acid compositions for improving central functions |
| 04/08/2004 | WO2004028525A1 Choline ascorbate formulations |
| 04/08/2004 | WO2004028521A2 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 04/08/2004 | WO2004028472A2 THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-β |
| 04/08/2004 | WO2004022573A3 Adenosine a3 receptor agonists |
| 04/08/2004 | WO2004016613A3 Purine derivatives and their use as antiproliferative agents |
| 04/08/2004 | WO2004016580A3 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid |
| 04/08/2004 | WO2004012722A3 Bicifadine formulation |
| 04/08/2004 | WO2004009565A3 Acylaminothiazole derivatives, preparation and therapeutic use thereof |
| 04/08/2004 | WO2004009061A3 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 04/08/2004 | WO2004006911A3 Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same |
| 04/08/2004 | WO2004000877A3 Peptides derived from the rabies virus glycoprotein g, ligands of the low-affinity receptor of neurotrophins (p75ntr) and applications thereof |
| 04/08/2004 | WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/08/2004 | WO2003106452A3 Antagonists of melanin concentrating hormone receptor |
| 04/08/2004 | WO2003106431A3 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 04/08/2004 | WO2003101392A3 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 04/08/2004 | WO2003101384A3 Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003092701A3 Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders |
| 04/08/2004 | WO2003092605A9 Protease inhibitors |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003084521A3 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 04/08/2004 | WO2003083135A3 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 04/08/2004 | WO2003082832A3 Anxiolytic agents with reduced sedative and ataxic effects |
| 04/08/2004 | WO2003076455A3 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
| 04/08/2004 | WO2003068732A3 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds |
| 04/08/2004 | WO2003068140A3 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003051276B1 Therapeutic heterocycles |
| 04/08/2004 | WO2003047519A3 'compressed annular tablet with molded triturate tablet for oral and intraoral' |
| 04/08/2004 | WO2003044037A3 Process for the manufacture of human mononuclear phagocytic leukocytes |
| 04/08/2004 | WO2003027068A3 Substituted amines for the treatment of neurological disorders |
| 04/08/2004 | WO2002085268A9 Disposal system for transdermal dosage form |
| 04/08/2004 | WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 04/08/2004 | US20040068118 Conjugated aromatic compounds with a pyridine substituent |
| 04/08/2004 | US20040068014 Medicinal compositions comprising diclofenac and ornoprostil |
| 04/08/2004 | US20040068005 Pharmaceutical combinations |
| 04/08/2004 | US20040067999 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 04/08/2004 | US20040067991 Tetrahydrobenzothiazole analogues as neuroprotective agents |
| 04/08/2004 | US20040067990 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 04/08/2004 | US20040067989 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents |
| 04/08/2004 | US20040067987 Antiarthritic agents; osteoporosis; anticancer agents |
| 04/08/2004 | US20040067986 Selegiline or procaine hydrochloride; vinpocetin with niacin, niacinamide or aminobutyric acid |
| 04/08/2004 | US20040067984 Psychological disorders; central nervous system disorders; cognition activators |
| 04/08/2004 | US20040067981 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 04/08/2004 | US20040067979 N-bridged selective androgen receptor modulators and methods of use thereof |
| 04/08/2004 | US20040067972 Acetylcholinesterase inhibitor; Alzheimer's disease; cognition activators; central nervous system disorders |
| 04/08/2004 | US20040067971 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 04/08/2004 | US20040067966 Adenosine receptor antagonists and methods of making and using the same |
| 04/08/2004 | US20040067963 Post-trauma stress disorders; administering serotinine reuptake inhibitor |
| 04/08/2004 | US20040067960 Central nervous system disorders; Alzheimers's, Parkinson's, Huntington disease |
| 04/08/2004 | US20040067959 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/08/2004 | US20040067957 Methods of treating or preventing restless leg syndrome using sibutramine metabolites |
| 04/08/2004 | US20040067956 Treatment of motor fluctuations |
| 04/08/2004 | US20040067955 Pyridazinone compound and pharmaceutical use thereof |
| 04/08/2004 | US20040067954 Benzoylpyridazines |
| 04/08/2004 | US20040067949 Substituted indoles which are parp inhibitors |
| 04/08/2004 | US20040067946 Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 04/08/2004 | US20040067943 Tryptase inhibitors |
| 04/08/2004 | US20040067941 Central nervous system disorders; anxiolytic agents; antidepressants; antiepilepsy agents; antiarthritic agents |
| 04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 04/08/2004 | US20040067937 Guanylate cyclase stimulant; cardiovascular disorders; thrombosis; antiischemic agents; sexual disorders; antiinflammatory agents; central nervous system disorders |
| 04/08/2004 | US20040067932 Synergistic mixture; anticancer agents; therapy for skin cancer |
| 04/08/2004 | US20040067931 Benzimidazolidinone derivatives as muscarinic agents |
| 04/08/2004 | US20040067930 Central nervous system disorders; neurotransmitters; side effect reduction |
| 04/08/2004 | US20040067928 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 04/08/2004 | US20040067918 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 04/08/2004 | US20040067888 Nucleic acid capable of binding to interferons |
| 04/08/2004 | US20040067538 Prevention and treatment of amyloid-associated disorders |
| 04/08/2004 | US20040067518 Isolated nucleic acid comprising a polynucleotide of given sequence; polypeptides; recombinant host cells; useful in diagnosing and treating disorders |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067270 Extract from family Euphorbaciae having reduced proanthocyandin content and concentraded lipophilic constituents. |
| 04/08/2004 | US20040067261 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 04/08/2004 | US20040067254 Paroxetine compositions and processes for making the same |
| 04/08/2004 | US20040067237 Using a rational selection of representative PspAs from various families of clades to produce broadly efficacious Pneumococcal vaccines |